ASA. P. Semagin

A. P. Semagin

*This is an algorithmically generated author record based on publicly available information.

A. P. Semagin has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immediate and mid-term results of the Ross and Ozaki procedures in adults

    by I.I. Chernov, S.T. Enginoev, A.B. Gamzaev, Komarov, V.A. Belov, V.B. Arutyunyan, B.K. Kadyraliev, A.P. Semagin, D.V. Kuznetsov, A.A. Zybin, et al.

    Objective. To compare the immediate and mid-term results of the AVNeo and Ross procedures for aortic valve disease in adults. Material and methods. After PSM, we distinguished 2 groups by 30 patients: group I — the AVNeo procedure (n=30), group II (n=30) — the Ross procedure. Inclusion criteria: patients aged ≥16 years who underwent the Ross or AVNeo surgery. There were no exclusion criteria. The median follow-up period was 27 [13; 76] months (24 [17; 32] and 80 [33; 103], respectively). Results. Demographic and preoperative clinical and echocardiographic characteristics after PSM did not differ between groups. Mean age of patients was 48 [37; 59] and 50 [42; 54] years, respectively (p=0.707). Surgery time was similar (220 vs 235 min, p=0.705). Cardiopulmonary bypass and myocardial ischemia time was significantly shorter after the AVNeo procedure (108 vs 148 min, p<0.001; 82 vs 115 min, p<0.001, respectively). In-hospital mortality did not differ significantly (3.3% (n=1) and 0, p=0.356). There were no differences in postoperative complications: resternotomy for bleeding (3.3% vs 0, p=1), implantation of permanent pacemaker (0 vs 3.3%, p=0.356), stroke (0 vs 3.3%, p=0.807). Sepsis, AKI and wound superficial infection were not observed in any patient. Three-year overall survival was lower in the AVNeo group (89.4% vs 100%, p=0.015). Three-year freedom from redo surgery was lower in the AVNeo group (79.7% vs 100%, p=0.034). Conclusion. In-hospital mortality and postoperative complications did not differ between groups. Overall 3-year survival and freedom from redo surgery were higher after the Ross procedure.

  • Open Access

    Comparison of the results of aortic valve neocuspidalization (Ozaki procedure) with aortic valve bioprosthetics in patients with a narrow aortic annulus: a multicenter retrospective study

    by B. K. Kadyraliev, V. A. Belov, A. V. Marchenko, V. B. Arutyunayan, I. I. Chernov, R. N. Komarov, B. M. Tlisov, A. B. Gamzaev, A. P. Semagin, D. V. Kuznetsov, et al.

    In aortic valve (AV) replacement surgery in patients with a narrow annulus fibrosus (AF), the likelihood of prosthesis-patient mismatch (PPM) is high. PPM, in turn, significantly affects the hemodynamic and functional capabilities of AV, morbidity and mortality in the postoperative period. The “gold standard” for the treatment of AV diseases is prosthetics with mechanical and biological prostheses. However, there are alternative methods, such as neocuspidalization of AV according to the S. Ozaki (AVNeo) method.Aim: To compare the immediate and medium-term results of AV prosthetics using the S. Ozaki (AVNeo) technique and AV prosthetics with a biological prosthesis in patients with a small aortic annulus.Material and Methods: A retrospective multicenter study of 309 patients with a narrow fibrous ring of the aortic valve (FR AV) who underwent surgery between February 2010 and December 2021 was conducted. Inclusion criteria: prosthetics of AV, FR AV = 21 mm, age 18 years and older. Exclusion criteria: left ventricle ejection fraction ≤ 40%, repeated interventions, mini-stop. 153 patients underwent Aveo and 156 patients underwent AV prosthetics using biological prostheses. After “pseudorandomization” (propensity score matching), 92 patients were selected: 46 patients in the AVNeo group and 46 patients in the biological prosthesis group. The primary endpoint was hospital mortality. Postoperative complications, transvalvular gradients, and medium-term outcomes (three-year overall survival and freedom from surgery on AV) were evaluated as secondary endpoints.Results. There was no statistically significant difference in the duration of surgery (275.9 ± 34.2 min in the AVNeo group and 285.8 ± 37 min in the bioprosthesis group, p < 0.4), artificial circulation (98 min in the AVNeo group and 115 min in the bioprosthesis group, p < 0.3), aortic compression (80 min in the AVNeo group and 93 min in the bioprosthesis group, p < 0.7). Hospital mortality among the studied patients did not differ: in the AVNeo group – 2 (4.3%) and 1 (2.2%) in the bioprosthesis group, p = 1.0. There were no significant differences in postoperative complications: wound surface infection (3 (6.5%) in the AVNeo group and 1 (2.2%) in the bioprosthesis group, p = 0.617), acute kidney injury (1 (2.2%) in the AVNeo group and 0 in the bioprosthesis group, p = 1.0), stroke ( 1 (2.2%) in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 1.0), resternotomy for bleeding (0 in the AVNeo group and 2 (4.3%) in the bioprosthesis group, p = 0.495). Permanent pacemaker implantation was not required by any patient. There was also no statistically significant difference in the three-year overall survival and re–operation, in the AVNeo group it was 83% and 92.5% in the bioprosthesis group, p = 0.23; three-year freedom from re-operation was 96.4% in the AVNeo group and 97.1% in the bioprosthesis group, p = 0.27. However, peak and average gradients were statistically less after AVNeo surgery. The peak and average gradients after AVNeo were 12 and 6 mmHg, after prosthetics 32 and 20 mmHg, p < 0.001.Conclusions: There was no statistically significant difference in hospital mortality, postoperative complications, and three-year survival and re-operation. The values of the peak and average pressure gradient at discharge differed statistically significantly in favor of the AVNeo group.


  • Open Access

    Short-term outcomes of the Tiara bioprosthesis and the Ozaki procedure comparison: a multicenter retrospective study with propensity score analysis

    by S. T. Enginoev, I. I. Chernov, V. N. Kolesnikov, B. K. Kadyraliev, V. A. Belov, V. B. Arutyunyan, R. N. Komarov, A. P. Semagin, D. V. Kuznetsov, A. A. Zybin, et al.

    Cardiac surgery research shows that isolated aortic valve (AV) procedures account for 9% of all cardiac surgeries, with a surgery mortality rate of 2.3% and the predominance of bioprosthese use. Despite the widespread use of these methods, there is a high rate of patient-prosthesis mismatch affecting long-term survival. In this context, new technologies are emerging, such as Tiara bioprostheses and Ozaki neocuspidization of AV, but their comparative analysis is currently lacking.Aim: to compare short-term outcomes of the Tiara bioprosthesis implantation and the Ozaki procedure.Methodology and Research Methods. Retrospective analysis of 387 patients who underwent Ozaki procedure or the Tiara bioprosthesis implantation was performed. Inclusion criteria are patient age 18 years or older, Ozaki procedure performed or the Tiara bioprosthesis implantation. Exclusion criteria are use of a mini-access, the presence of infective endocarditis and repeated cardiac surgery. Ultimately, 352 patients were selected. Given the statistically significant differences in clinical and demographic characteristics between the groups, a propensity score matching was used in a 1 : 1 ratio. As a result two balanced groups of 58 patients each were formed.Results. In the group, where the Tiara bioprosthesis was implanted, the average age was 69 ± 5 years. In the group, where the Ozaki procedure was performed, the average age was 68 ± 6 years (p = 0.3). There were 14 men and 44 women in the Tiara group and 21 men and 37 women in the Ozaki group (p = 0.1). The median diameter of the annulus in the Tiara group was 20 (20–22) mm, while in the Ozaki group it was 21 (20–22) mm (p = 0.2). Statistically significant differences were noted in the duration of the surgery, cardiopulmonary bypass and cross-clamp time, which were statistically less in the Tiara group compared to the Ozaki group: surgery duration – 160 (145–199) minutes versus 250 (220–295) minutes (p < 0.001 ), cardiopulmonary bypass time – 72 (60–97) minutes versus 112 (92–133) minutes (p < 0.001), cross-clamp time – 55 (46–70) minutes versus 81 (71–100) minutes (p < 0.001). There was no statistically significant difference between the groups in terms of postoperative complications and hospital mortality. In-hospital mortality was 0% versus 2 (3.4%) cases (p = 0.4). Resternotomy due to bleeding was performed in 1 patient (1.7%) in the Tiara group and in 4 patients (6.9%) in the Ozaki group (p = 0.3). Pacemaker implantation was required in 2 patients (3.4%) in the Tiara group, whereas such a need did not arise in the Ozaki group (p = 0.4). Stroke occurred in 4 patients (6.9%) in the Tiara group and in 1 patient (1.7%) in the Ozaki group (p = 0.3). Acute kidney injury was recorded only in 1 patient in the Ozaki group (1.7%) (p = 1). Both groups had similar rates of patient-prosthesis mismatch; moderate discrepancy was noted in only one patient (1.7%) in the Tiara group; no such cases were recorded in the Ozaki group. However, significant differences were found in peak and mean gradients on AV. In the Tiara group, the peak gradient was 32 ± 12 mmHg, and the average was 17 (11–20) mmHg. In comparison, in the Ozaki group the average values were significantly lower: peak gradient – 11 ± 5 mmHg, average – 5 (3–8) mmHg. (p < 0.001 for both comparisons).Conclusion. The study showed that the surgery duration, cardiopulmonary bypass, and myocardial ischemia period was statistically significantly shorter in the Tiara group compared with the Ozaki group. Despite this, transvalvular gradients on the AV were smaller in the Ozaki group.

  • Three-year results of aortic valve neocuspidization (Ozaki procedure): a multiple-center retrospective study

    by S.T. Enginoev, I.I. Chernov, Komarov, V.A. Belov, A.B. Gamzaev, V.B. Arutyunyan, B.K. Kadyraliev, A.P. Semagin, A.M. Ismailbaev, D.V. Kuznetsov, et al.

    Objective. To analyze 3-year outcomes after Ozaki procedure. Material and methods. A retrospective multiple-center study included 251 patients with aortic valve disease between January 2017 and February 2020. Results. The main indication for surgery was severe aortic stenosis in 230 (91.6%) cases, bicuspid aortic valve in 88 (35%) cases, aortic regurgitation (AR) in 21 (8.4%) cases and infective endocarditis (IE) in 12 (4.8%) cases. The sample included 116 (46.2%) men and 135 (53.8%) women (mean age 66 (60—70) years). There were no conversions of the Ozaki procedure to aortic valve replacement with biological or mechanical prostheses. Xenopericardium was used in 7 cases due to redo surgeries. Combined interventions were performed in 103 (42.2%) patients. In-hospital mortality was 1.2%. Two (0.8%) patients underwent redo sternotomy for bleeding. Follow-up was completed in all patients (median period 24 (17—32) months). Three-year survival and freedom from redo surgeries were 90.6% and 94.6%, respectively. Postoperative echocardiography revealed mean pressure gradient 6 mm Hg. AR ≥2 was detected in 13 (8.3%) patients in 22.6±9.9 months after surgery. Baseline IE (p=0.04) and AR ≥2 (p=0.006) at discharge are significant predictors of aortic valve dysfunction after Ozaki surgery. Conclusion. The Ozaki procedure in patients with aortic valve disease has favorable immediate results regarding in-hospital mortality and postoperative morbidity, as well as optimal intermediate results regarding survival, freedom from redo surgeries and hemodynamic parameters. Further monitoring of patients is necessary to assess the long-term results after this procedure.

  • Rupture-oriented strategy for acute type A aortic dissection

    by D.V. Kuznetsov, A.P. Semagin, A.A. Zybin, A.A. Gevorgyan, M.V. Polyaeva, N.N. Sidorenko, S.M. Khokhlunov

    OBJECTIVE To evaluate the immediate and long-term results of surgical treatment of acute aortic dissection type A using rupture-oriented strategy. MATERIAL AND METHODS A prospective study included 157 patients with acute aortic dissection type A who were divided into 2 groups: group 1 — 123 people (inner wall rupture in ascending aorta or lesser curvature of aortic arch) underwent ascending aorta replacement and, if necessary, hemiarch procedure, group 2 — 34 patients (inner wall rupture in aortic arch (except for lesser curvature) or no rupture in ascending aorta and aortic arch, aortic arch aneurysm) underwent ascending aorta and aortic arch replacement. Early and late postoperative results were assessed. RESULTS In-hospital mortality was similar (13.8% and 14.7%, respectively, p=0.9). Early postoperative morbidity (bleeding, myocardial infarction, neurological complications, acute renal failure) was similar. Five-year survival rate was 74% and 82%, respectively (p=0.97), five-year freedom from redo aortic surgery — 88% and 90%, respectively (p=0.75). CONCLUSION Rupture-oriented surgical strategy for acute aortic dissection type A may be used without worsening immediate and long-term results, especially in hospitals without extensive experience in aortic surgery.


  • Open Access

    Aortic valve hemodynamic characteristics after the Ozaki procedure according to echocardiography: a multicenter retrospective study

    by T. K. Rashidova, S. T. Enginoev, I. I. Chernov, V. N. Kolesnikov, R. N. Komarov, V. A. Belov, A. B. Gamzaev, V. B. Arutyunyan, B. K. Kadyraliev, A. P. Semagin, et al.

    Aim. To evaluate the aortic valve (AV) hemodynamic characteristics after the Ozaki procedure according to echocardiography.Material and methods. The retrospective multicenter study included 277 patients with AV defects who were operated on from January 2017 to June 2022 in five centers in Russia. After the Ozaki procedure, the following endpoints were assessed: immediate echocardiographic results (peak AV gradient, mean AV gradient, AV effective orifice area, aortic regurgitation grade), mid-term clinical (three-year survival rate, three-year freedom from reoperation, three-year freedom from grade ≤2 aortic regurgitation) and echocardiographic results (peak and mean AV gradient, AV effective orifice area, aortic regurgitation grade, AV calcification severity). The median follow-up period was 23 (13-32) months. The mean echocardiography follow-up period was 21±10 months.Results. During the treatment, a decrease in the peak AV gradient was observed from 74±30 mm Hg before surgery up to 12 (8-16) mm Hg one week after surgery, which remained in the mid-term period — 12 (9-15) mm Hg. There was also a decrease in the mean gradient from 40 (27-53) mm Hg before surgery up to 6 (4-8) mm Hg one week after surgery. By the mid-term period, the mean gradient was 6 (4-8) mm Hg. The AV effective orifice area increased from 1 (1-1) cm2 to 2 (2-2) cm2 in the mid-term follow-up period. Three-year survival rate was 90,2%, freedom from reoperation was 95%, freedom from grade ³2 aortic regurgitation was 88%, and no patient had AV calcification.Conclusion. The Ozaki procedure in patients with AV defects has good immediate and mid-term hemodynamic parameters according to echocardiography. However, there remains a need for large randomized controlled trials comparing Ozaki procedure with biological AV replacement.

  • Gender differences in the outcomes after ascending aortic and aortic arch surgery

    by E.R. Charchyan, D.V. Kuznetsov, A.P. Semagin, A.A. Zybin, A.A. Gevorgyan, G.A. Malgin

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка гендерных различий у пациентов с патологией восходящего отдела и дуги аорты в ближайшем послеоперационном периоде. МАТЕРИАЛ И МЕТОДЫ В проспективное исследование включены 806 пациентов с патологией восходящего отдела и дуги аорты, которые разделены на группы: 1-я группа — 204 женщины, 2-я группа — 602 мужчины. Пациентам проведено протезирование восходящего отдела аорты, дуги аорты в ГНЦ ФГБНУ «РНЦХ им. Б.В. Петровского» с 2017 по 2021 г. и ГБУЗ «Самарский областной клинический кардиологический диспансер им. В.П. Полякова» с 2013 по 2021 г. Оценивали предоперационные данные, операционные показатели, течение раннего послеоперационного периода и госпитальную летальность. Выявляли предикторы госпитальной летальности. РЕЗУЛЬТАТЫ Тридцатидневная летальность у женщин была достоверно выше (7,4 и 3,1% у женщин и мужчин соответственно, p=0,02). Женщины дольше находились на ИВЛ (15±14 и 12±10 ч соответственно, p=0,02). Средняя кровопотеря в 1 сутки после операции была выше у женщин (887±852 и 780±442 мл соответственно, p=0,03). Частота неврологических осложнений также была выше у женщин (3,9% против 1,2%, p=0,01). Независимые предикторы 30-дневной летальности у мужчин включали курение, креатинин плазмы крови >110 ммоль/л, сердечную недостаточность II-IV функциональных классов по NYHA, экстренность операции, время пережатия аорты >120 мин; у женщин — экстренность операции и креатинин плазмы крови >100 ммоль/л. ВЫВОД Хирургическое лечение больных женского пола с патологией восходящего отдела и дуги аорты связано с более тяжелым течением раннего послеоперационного периода и более высокой 30-дневной послеоперационной летальностью.


  • Open Access

    Aortic Valve Reinterventions after Ozaki: Clinical Case Series from Four Centers

    by S. T. Enginoev, I. I. Chernov, R. N. Komarov, V. A. Belov, V. B. Arutyunyan, B. K. Kadyraliev, A. P. Semagin, D. V. Kuznetsov, A. A. Zybin, A. M. Ismailbaev, et al.

    Introduction. One of surgical methods for treatment of aortic valve (AV) pathology is Aortic Valve Neocuspidalization Ozaki procedure (AVNeo). Thus, according to the latest systematic review, freedom from reoperation within one, three, five years after AVNeo was 98%, 97% and 96%. Available references provide few descriptions of reoperations after AVNeo. Aim. To analyze the immediate results of AV reinterventions after AVNeo. Materials and methods. In the medium term, reinterventions after AVNeo were necessary for 11 patients (4.3%). The age of patients ranged from 26 to 69 years. 11 patients who underwent surgery included 6 males and 5 females. Four patients had class III-IV CHF, according to NYHA classification. Three patients had previously been operated on for infective endocarditis (IE), and five patients had bicuspid aortic valve. The duration of follow-up, from AVNeo surgery to reinterventions, ranged from 3 to 43 months. Results and discussion. All patients underwent an isolated AV intervention. The main causes of dysfunction were IE (six patients) and leaflet rupture in the commissural area (five patients). Seven patients underwent aortic valve replacement with mechanical valves, one patient — with aortic homograft valve, one patient — with tissue valve and two patients underwent valve repair. In the early postoperative period, one patient had bleeding with the development of cardiac tamponade and one patient had a haemorrhagic stroke. No patients had ARF, perioperative myocardial damage, sternal infection or permanent pacemaker implantation. Two patients died during the hospital period. Conclusions. AV reinterventions are associated with a high incidence of complications and deaths. Therefore, prevention of IE and commissure enhancement should reduce the frequency of repeated interventions, which is to be confirmed by prospective studies in large cohorts of patients.


  • Open Access

    Gender comparison of immediate and medium-term results of Ozaki operation: a Propensity Score Matching Analysis

    by S. T. Enginoev, I. I. Chernov, R. N. Komarov, D. G. Tarasov, A. P. Semagin, V. B. Arutyunyan, B. K. Kadyraliev, A. M. Ismailbaev, D. V. Kuznetsov, A. A. Zybin, et al.

    Highlights. A retrospective analysis of the patients’ data after Ozaki operation in four Russian Medical Centers was carried out. A comparative gender assessment of the immediate and medium-term results of Ozaki operation was performed.Aim. Gender assessment of Ozaki operation immediate and mid-term results in patients with aortic valve (AV) pathology.Methods. A retrospective multicenter study enrolled 251 patients (135 women, median age 66 (60–70) years old) who underwent Ozaki operation (2017–2020) was carried out in four centers in Russia. After propensity score matching, 92 patients were selected (mean age 65.8±10.8 years old). Two groups were formed in the gender structure: 46 females (average age 67.8±6.3 years old), 46 males (average age 63.8±15.4 years old). The main cause of AV dysfunction was severe aortic stenosis – in 86 (93.5%) cases. Chronic heart failure of III–IV functional class according to NYHA was observed in 26 (28.3%) patients. A bicuspid AV was in 24 cases (26.1%). The primary endpoint was hospital mortality. Postoperative complications and mid-term results (three-year overall survival and freedom from reoperation on AV) were assessed as secondary endpoints; the median follow-up period was 23 (18–33) months.Results. There was no statistically significant difference between the groups in the duration of surgery (275 minutes for females and 285 minutes for males, p = 0.4), cardiopulmonary bypass (98 minutes for females and 115 minutes for males, p = 0.3), aortic clamping (80 minutes for females and 93 minutes for males, p = 0.7). Hospital mortality among the studied patients did not differ: in the female group – 2.2% (1 case) and 0 in the male one, p = 0.9. There were no significant differences in postoperative complications: sepsis (2.2% in women and 0 in men, p = 0.9), superficial wound infection (8.7% in women and 6.5% in men, p = 0.9). Acute kidney injury, stroke, pacemaker implantation, resternotomy for bleeding were not observed in any patient. Three-year overall survival was 91.8% in females and 91.6% in males, p = 0.8; three-year freedom from reoperation – 94.4% for females and 100% for males, p = 0.1.Conclusion. Ozaki operation is equally reproducible with the same hospital mortality, postoperative complications, and medium-term outcomes in both females and males.

  • Risk of infective endocarditis after aortic valve neocuspidization (Ozaki procedure): a multiple-center study

    by S.T. Enginoev, I.I. Chernov, Komarov, Yu.S. Sinelnikov, A.P. Semagin, V.B. Arutyunayan, V.A. Chragyan, B.K. Kadyraliev, A.S. Pisaryuk, A.M. Ismailbaev, et al.